MammoCoach will debut at RSNA 2014 an online teaching product for screening mammography.
MammoCoach will debut at RSNA 2014 its online teaching product that earns recipients CME and improves their screening mammography skills, the company announced.
The tool is devised to increase a readers experience to more than 1000 mammograms, MammoCoach said. MammoCoach was developed by a team of experts from academia, private practice, industry, and public health.
MammoCoach includes a cloud-based collection of 1000 screening mammograms, including two-year-old prior studies on a viewer with hanging protocols to evaluate the cases in a timely fashion. Among the cases are 100 recalls, including diagnostic work-up and a final amount of 3–5 malignancies, as well as access to a large electronic case collection to further retrain certain aspects of breast imaging, the company said. Cases can be reviewed with feedback from faculty, comparison with peers, and learning cases.
The tool also provides a feature that shows the user when other readers, including the five most experienced super readers, decided not to call the patient back based on specific criteria.
MammoCoach is self-proclaimed as “the first online teaching program focusing on coaching screening mammography skills under realistic conditions.”
[[{"type":"media","view_mode":"media_crop","fid":"29686","attributes":{"alt":"MammoCoach","class":"media-image media-image-right","id":"media_crop_2148978577820","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3087","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 153px; width: 441px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.